These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15589056)

  • 1. Additive effect of the combination of glatiramer acetate and minocycline in a model of MS.
    Giuliani F; Metz LM; Wilson T; Fan Y; Bar-Or A; Yong VW
    J Neuroimmunol; 2005 Jan; 158(1-2):213-21. PubMed ID: 15589056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment with atorvastatin and minocycline suppresses severity of EAE.
    Luccarini I; Ballerini C; Biagioli T; Biamonte F; Bellucci A; Rosi MC; Grossi C; Massacesi L; Casamenti F
    Exp Neurol; 2008 May; 211(1):214-26. PubMed ID: 18346732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined treatment of Copaxone and Salirasib attenuates experimental autoimmune encephalomyelitis (EAE) in mice.
    Aizman E; Mor A; Chapman J; Assaf Y; Kloog Y
    J Neuroimmunol; 2010 Dec; 229(1-2):192-203. PubMed ID: 20869125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.
    Chen X; Hu X; Zou Y; Pi R; Liu M; Wang T; Zheng X; Liu M; Lin M; Liu P; Tao L
    J Neuroimmunol; 2009 May; 210(1-2):22-9. PubMed ID: 19344957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of methylprednisolone and minocycline synergistically improves experimental autoimmune encephalomyelitis in C57 BL/6 mice.
    Chen X; Pi R; Liu M; Ma X; Jiang Y; Liu Y; Mao X; Hu X
    J Neuroimmunol; 2010 Sep; 226(1-2):104-9. PubMed ID: 20538348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.
    Ruggieri M; Pica C; Lia A; Zimatore GB; Modesto M; Di Liddo E; Specchio LM; Livrea P; Trojano M; Avolio C
    J Neuroimmunol; 2008 Jul; 197(2):140-6. PubMed ID: 18555539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis.
    Begum-Haque S; Sharma A; Christy M; Lentini T; Ochoa-Reparaz J; Fayed IF; Mielcarz D; Haque A; Kasper LH
    J Neuroimmunol; 2010 Feb; 219(1-2):47-53. PubMed ID: 20034680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
    Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
    Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prospects of minocycline in multiple sclerosis.
    Chen X; Ma X; Jiang Y; Pi R; Liu Y; Ma L
    J Neuroimmunol; 2011 Jun; 235(1-2):1-8. PubMed ID: 21565409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
    Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R
    Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective combination of minocycline and interferon-beta in a model of multiple sclerosis.
    Giuliani F; Fu SA; Metz LM; Yong VW
    J Neuroimmunol; 2005 Aug; 165(1-2):83-91. PubMed ID: 15958276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
    Kala M; Rhodes SN; Piao WH; Shi FD; Campagnolo DI; Vollmer TL
    Exp Neurol; 2010 Jan; 221(1):136-45. PubMed ID: 19879259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses.
    Papadopoulos D; Rundle J; Patel R; Marshall I; Stretton J; Eaton R; Richardson JC; Gonzalez MI; Philpott KL; Reynolds R
    J Neurosci Res; 2010 Feb; 88(2):346-59. PubMed ID: 19658199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minocycline delays but does not attenuate the course of experimental autoimmune encephalomyelitis in Streptococcus pneumoniae-infected mice.
    Herrmann I; Kellert M; Spreer A; Gerber J; Eiffert H; Prinz M; Nau R
    J Antimicrob Chemother; 2007 Jan; 59(1):74-9. PubMed ID: 17079237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glatiramer acetate in combination with minocycline in patients with relapsing--remitting multiple sclerosis: results of a Canadian, multicenter, double-blind, placebo-controlled trial.
    Metz LM; Li D; Traboulsee A; Myles ML; Duquette P; Godin J; Constantin M; Yong VW;
    Mult Scler; 2009 Oct; 15(10):1183-94. PubMed ID: 19776092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
    Aharoni R
    J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
    Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis.
    Jee Y; Piao WH; Liu R; Bai XF; Rhodes S; Rodebaugh R; Campagnolo DI; Shi FD; Vollmer TL
    Clin Immunol; 2007 Oct; 125(1):34-42. PubMed ID: 17632037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL; Wolak K; Fournier S; David S
    Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.